Zydus Lifesciences Shows Strong Financial Growth and Market Resilience Amid Evaluation Adjustment
Zydus Lifesciences has recently experienced an evaluation adjustment, reflecting its strong market position. The company reported a record net sales figure of Rs 6,573.70 crore and demonstrated impressive growth rates, alongside a low debt-to-equity ratio, highlighting its financial stability and robust performance over the past nine quarters.
Zydus Lifesciences, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment that reflects its evolving market position. The company has demonstrated a robust financial profile, highlighted by a significant annual growth rate in net sales of 10.59% and an impressive operating profit growth of 22.64%. This performance is underpinned by a low debt-to-equity ratio of 0.06 times, indicating a strong balance sheet and financial stability.In the latest quarter, Zydus Lifesciences reported a record net sales figure of Rs 6,573.70 crore, alongside cash and cash equivalents reaching Rs 2,956.80 crore, showcasing its liquidity strength. The company's return on equity stands at an average of 19.49%, reflecting its ability to generate substantial profits relative to shareholders' funds.
Zydus Lifesciences has consistently delivered positive results over the last nine consecutive quarters, reinforcing its reputation as a reliable investment. The stock's performance over various time frames, including a notable 177.01% return over three years, positions it favorably within the market.
This recent evaluation adjustment highlights the company's strong fundamentals and market resilience, making it a noteworthy entity in the large-cap space.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
